Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Trajan Group Holdings Ltd ( (AU:TRJ) ) has shared an update.
Trajan Group Holdings has announced the resignation of Chief Financial Officer and Joint Company Secretary Alister Hodges, who will leave the company on 11 November 2026 after more than 15 years of service. The board has launched a formal executive search for his successor and put interim arrangements in place to ensure business continuity, underscoring an orderly leadership transition following Hodges’ key role in Trajan’s growth, acquisitions integration, and IPO.
CEO and Managing Director Stephen Tomisich publicly thanked Hodges for his long-term commitment and contributions to Trajan’s expansion and capital markets journey. The change in financial leadership marks a notable shift in the company’s executive team but, with planned succession and continuity measures, is not expected to disrupt ongoing operations or its strategic growth trajectory in the analytical and life sciences sector.
The most recent analyst rating on (AU:TRJ) stock is a Buy with a A$1.00 price target. To see the full list of analyst forecasts on Trajan Group Holdings Ltd stock, see the AU:TRJ Stock Forecast page.
More about Trajan Group Holdings Ltd
Trajan Group Holdings Limited is a global analytical science and device company that develops and manufactures analytical and life sciences products and devices. Its tools and solutions are used to analyze biological, food, and environmental samples, with a portfolio focused on supporting the shift toward decentralized, personalized, data-based healthcare across operations in Australia, the U.S., Asia, and Europe.
Average Trading Volume: 32,976
Technical Sentiment Signal: Sell
Current Market Cap: A$70.17M
See more insights into TRJ stock on TipRanks’ Stock Analysis page.